• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Triplet structure of human von Willebrand factor.人血管性血友病因子的三联体结构
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):483-8. doi: 10.1042/bj3310483.
2
Selectivity of von Willebrand factor triplet bands towards heparin binding supports structural model.血管性血友病因子三联体带对肝素结合的选择性支持结构模型。
Eur J Haematol. 1999 Mar;62(3):169-73. doi: 10.1111/j.1600-0609.1999.tb01740.x.
3
Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.血管性血友病因子的三联体结构反映了高分子量多聚体的蛋白水解降解。
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7503-7. doi: 10.1073/pnas.90.16.7503.
4
Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: implication for the interpretation of satellite bands.比较天然多聚体分析和变性分离的血浆和血小板血管性血友病因子:对卫星带解释的影响。
Electrophoresis. 2011 Jun;32(13):1684-91. doi: 10.1002/elps.201000662. Epub 2011 Jun 6.
5
Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin.对在共表达重组弗林蛋白酶的转化CHO细胞的工业规模发酵中产生的重组血管性血友病因子进行结构分析。
FEBS Lett. 1995 Nov 20;375(3):259-62. doi: 10.1016/0014-5793(95)01218-4.
6
Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.由组成亚基的蛋白水解作用导致的血浆血管性血友病因子多聚体的异质性。
J Clin Invest. 1991 Sep;88(3):774-82. doi: 10.1172/JCI115376.
7
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.血管性血友病的一种新变体(帕多瓦I型):在所有大小的多聚体存在下,由双重结构组成的血浆血管性血友病因子寡聚体
Haematologia (Budap). 1994;26(2):97-109.
8
Disulfide bonds required to assemble functional von Willebrand factor multimers.组装功能性血管性血友病因子多聚体所需的二硫键。
J Biol Chem. 1994 Mar 4;269(9):6753-8.
9
Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.关于血管性血友病因子上存在因子VIII的二级结合和保护位点的证据极不可能。
Biochem J. 1992 Feb 15;282 ( Pt 1)(Pt 1):129-37. doi: 10.1042/bj2820129.
10
Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain.金黄色葡萄球菌V-8蛋白酶对人血管性血友病因子的有限蛋白水解作用:血小板结合结构域的分离与部分特性分析
Biochemistry. 1986 Jun 3;25(11):3156-63. doi: 10.1021/bi00359a013.

引用本文的文献

1
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.第三届奥兰群岛血管性血友病会议,2012 年 9 月 26-28 日:会议报告。
Haemophilia. 2013 Mar;19 Suppl 3(0 3):1-18. doi: 10.1111/hae.12078.
2
ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?血栓性血小板减少性紫癜血浆置换过程中ADAMTS-13和血管性血友病因子与血小板反应的关系:疾病机制的线索?
Ann Hematol. 2009 Oct;88(10):1025-8. doi: 10.1007/s00277-009-0709-7. Epub 2009 Feb 11.
3
Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage.在生物技术过程中使用重组 Furin 的策略:完全切割目标蛋白前体。
Cytotechnology. 1999 Jul;30(1-3):1-16. doi: 10.1023/A:1008030407679.
4
Mechanistic studies on ADAMTS13 catalysis.ADAMTS13催化作用的机制研究。
Biophys J. 2008 Sep;95(5):2450-61. doi: 10.1529/biophysj.108.131532. Epub 2008 May 23.
5
Sodium dodecyl sulfate agarose gel electropheresis and electroelution of high molecular weight human salivary mucin.十二烷基硫酸钠琼脂糖凝胶电泳及高分子量人唾液粘蛋白的电洗脱
Clin Oral Investig. 2005 Dec;9(4):284-6. doi: 10.1007/s00784-005-0007-2. Epub 2005 Aug 25.
6
Recombinant von Willebrand factor: potential therapeutic use.重组血管性血友病因子:潜在的治疗用途。
J Thromb Thrombolysis. 1999 Oct;8(3):197-205. doi: 10.1023/a:1008906103637.

本文引用的文献

1
Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.人源及重组血管性血友病因子多聚化对血小板聚集、与胶原蛋白结合及凝血因子 VIII 结合的影响。
Thromb Res. 1996 Oct 1;84(1):55-66. doi: 10.1016/0049-3848(96)00161-2.
2
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.从人血浆中部分纯化并鉴定一种蛋白酶,该蛋白酶可将血管性血友病因子切割成体内蛋白水解产生的片段。
Blood. 1996 May 15;87(10):4223-34.
3
Therapy of von Willebrand disease.血管性血友病的治疗
Semin Thromb Hemost. 1993;19(1):37-47. doi: 10.1055/s-2007-994004.
4
von Willebrand factor.血管性血友病因子
FASEB J. 1993 Feb 1;7(2):308-16. doi: 10.1096/fasebj.7.2.8440408.
5
Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.血管性血友病因子的三联体结构反映了高分子量多聚体的蛋白水解降解。
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7503-7. doi: 10.1073/pnas.90.16.7503.
6
Proteolysis of von Willebrand factor in therapeutic plasma concentrates.治疗性血浆浓缩物中血管性血友病因子的蛋白水解作用。
Blood. 1994 May 15;83(10):3018-27.
7
Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin.对在共表达重组弗林蛋白酶的转化CHO细胞的工业规模发酵中产生的重组血管性血友病因子进行结构分析。
FEBS Lett. 1995 Nov 20;375(3):259-62. doi: 10.1016/0014-5793(95)01218-4.
8
The complex multimeric composition of factor VIII/von Willebrand factor.因子VIII/血管性血友病因子的复杂多聚体组成。
Blood. 1981 Jun;57(6):1140-3.
9
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定分子量的可靠性。
J Biol Chem. 1969 Aug 25;244(16):4406-12.
10
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.

人血管性血友病因子的三联体结构

Triplet structure of human von Willebrand factor.

作者信息

Fischer B E, Thomas K B, Schlokat U, Dorner F

机构信息

IMMUNO AG, Biomedical Research Center, Uferstrasse. 15, A-2304 Orth/Donau, Austria.

出版信息

Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):483-8. doi: 10.1042/bj3310483.

DOI:10.1042/bj3310483
PMID:9531488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1219379/
Abstract

Human von Willebrand factor (hp-vWF) is a high-molecular- mass protein found in plasma as a series of multimers. It consists of subunits comprising 2050 amino acids linked by disulphide bonds into multimers of various size ranging in molecular mass up to greater than 10000kDa. Partial proteolysis at position Tyr842-Mer843 of the subunit [Dent et al. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 6306-6310] by a vWF-specific protease [Furlan et al. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 7503-7507] results in the generation of an N-terminal and a C-terminal fragment and the appearance of hp-vWF triplet bands. It has been suggested [Furlan et al. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 7503-7507] that (i) the intermediate triplet band of the primary dimer represents a dimer of two C-terminal fragments, (ii) the slower migrating satellite band of the primary dimer represents an asymmetric structure composed of a mature subunit to which one N-terminal and one C-terminal fragment are linked by disulphide bonds, and (iii) the faster migrating satellite band of the primary dimer contains two N-terminal fragments. Here we used recombinant vWF (r-vWF) for structural analysis of hp-vWF multimers. r-vWF exhibited no proteolytic degradation and all multimers contained mature subunits. High-resolution agarose-gel electrophoresis and two-dimensional electrophoresis demonstrated that (i) r-vWF multimers and hp-vWF intermediate triplet bands exhibited identical molecular mass and electrophoretic mobilities, (ii) the faster and slower migrating satellite bands of hp-vWF differ by less than the molecular mass of one subunit from the corresponding intermediate triplet band, and (iii) the triplet bands of hp-vWF are composed of mature and degraded subunits. The results support a structural model of hp-vWF triplet bands according to which the intermediate triplet bands represent multiple numbers of symmetric and/or asymmetric dimers, the slower migrating satellite bands have one extra N-terminal fragment, and the faster migrating satellite band lacks one N-terminal fragment respectively in comparison with the corresponding intermediate triplet band.

摘要

人血管性血友病因子(hp-vWF)是一种在血浆中以一系列多聚体形式存在的高分子量蛋白质。它由包含2050个氨基酸的亚基组成,这些亚基通过二硫键连接形成各种大小的多聚体,分子量高达大于10000kDa。血管性血友病因子特异性蛋白酶[Furlan等人(1993年)《美国国家科学院院刊》90, 7503 - 7507]在亚基的Tyr842-Mer843位点进行部分蛋白水解[Dent等人(1990年)《美国国家科学院院刊》87, 6306 - 6310],导致产生一个N端片段和一个C端片段,并出现hp-vWF三联体条带。有人提出[Furlan等人(1993年)《美国国家科学院院刊》90, 7503 - 7507]:(i)初级二聚体的中间三联体条带代表两个C端片段的二聚体;(ii)初级二聚体迁移较慢的卫星条带代表一种不对称结构,由一个成熟亚基组成,一个N端片段和一个C端片段通过二硫键与之相连;(iii)初级二聚体迁移较快的卫星条带包含两个N端片段。在此,我们使用重组血管性血友病因子(r-vWF)对hp-vWF多聚体进行结构分析。r-vWF未表现出蛋白水解降解,所有多聚体均包含成熟亚基。高分辨率琼脂糖凝胶电泳和二维电泳表明:(i)r-vWF多聚体和hp-vWF中间三联体条带表现出相同的分子量和电泳迁移率;(ii)hp-vWF迁移较快和较慢的卫星条带与相应的中间三联体条带相比,分子量差异小于一个亚基的分子量;(iii)hp-vWF的三联体条带由成熟和降解的亚基组成。这些结果支持了hp-vWF三联体条带的结构模型,根据该模型,中间三联体条带代表多个对称和/或不对称二聚体,迁移较慢的卫星条带比相应的中间三联体条带多一个N端片段,迁移较快的卫星条带比相应的中间三联体条带少一个N端片段。